Journey Medical Corporation
DERM
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycyclā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
3 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$9.11
Price-0.87%
-$0.08
1Y
Price
Market Cap
$222.199m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-11.4%
EBITDA Margin-25.3%
Net Profit Margin-18.9%
Free Cash Flow MarginRevenue
$56.397m
+0.5%
1y CAGR-7.0%
3y CAGR-1.1%
5y CAGREarnings
-$8.738m
+40.4%
1y CAGR-51.1%
3y CAGR-30.2%
5y CAGREPS
-$0.39
+45.8%
1y CAGR-36.5%
3y CAGR-19.0%
5y CAGRBook Value
$19.246m
$81.158m
Assets$61.912m
Liabilities$25.277m
DebtDebt to Assets
31.2%
-21.3x
Debt to EBITDAFree Cash Flow
-$6.940m
+24.0%
1y CAGR-1259.4%
3y CAGR-988.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company